Prurigo Nodularis Treatment Market
According to Intent Market Research, the Prurigo Nodularis Treatment Market is expected to grow from USD 211.8 million in 2024-e at a CAGR of 12.1% to touch USD 421.3 million by 2030. The Prurigo Nodularis Treatment Market is dominated by key players such as, Amgen Inc., AbbVie Inc., Regeneron Pharmaceuticals Inc., Merck & Co., Inc., and Johnson & Johnson.